INA

Ina Research

GLP-certifiedAccepting studies

GLP toxicology & non-human-primate safety studies.

Preclinical / GLP laboratoryIna, Nagano, JapanJapanEst. 1981 · 45y700 staffWebsite

Open room Compare

Overview Capabilities Study capabilities Animal models Regulatory Locations Team

Animal-model database

Broad models · 71

Illustrative — species, strains, disease models, regulatory acceptance & availability.

Species / strain	Model type	Disease area	Regulatory	Availability
DogBeagle	Outbred strain	General toxicology	FDA/EMA accepted	Limited · 600 cap.
MouseC57BL/6	Inbred strain	Immunology	FDA/EMA accepted	Readily available · 20,000 cap.
MouseBALB/c	Inbred strain	—	FDA/EMA accepted	Readily available · 15,000 cap.
Non-human primateCynomolgus macaque	Outbred strain	Biologics safety	FDA/EMA accepted	Limited · 1,500 cap.
RabbitNew Zealand White	Outbred strain	Repro / teratology	FDA/EMA accepted	Readily available · 2,000 cap.
RatSprague-Dawley	Outbred strain	General toxicology	FDA/EMA accepted	Readily available · 12,000 cap.
RatWistar Han	Outbred strain	—	FDA/EMA accepted	Readily available · 8,000 cap.

INA

Ina Research

Preclinical / GLP · Japan

Live record · illustrative seed data · scores deterministic, rules-based — not AI · regulatory signals are educational, not a compliance determination.